Hubei Cancer Hospital ( Site 3012)

Wuhan, Hubei 430079

0 studies enrolling now · 1 studies all time

What they study most

Gastroesophageal Cancer

Studies at this site

• A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) — Running, not enrolling